Share on StockTwits

Gentiva Health Services (NASDAQ:GTIV) hit a new 52-week low on Monday , Stock Ratings Network reports. The stock traded as low as $8.31 and last traded at $8.48, with a volume of 236,496 shares changing hands. The stock had previously closed at $8.80.

GTIV has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of Gentiva Health Services from an “outperform” rating to an “underperform” rating in a research note on Thursday, March 20th. They now have a $8.25 price target on the stock. Separately, analysts at Piper Jaffray cut their price target on shares of Gentiva Health Services from $14.00 to $12.00 in a research note on Wednesday, March 5th. Finally, analysts at Sidoti initiated coverage on shares of Gentiva Health Services in a research note on Thursday, January 23rd. They set a “buy” rating on the stock. Four research analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the stock. Gentiva Health Services has an average rating of “Hold” and a consensus price target of $11.05.

The stock’s 50-day moving average is $9.58 and its 200-day moving average is $11.30. The company’s market cap is $311.8 million.

Gentiva Health Services (NASDAQ:GTIV) last announced its earnings results on Tuesday, March 4th. The company reported $0.14 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.30 by $0.16. The company had revenue of $486.10 million for the quarter, compared to the consensus estimate of $496.51 million. During the same quarter in the prior year, the company posted $0.31 earnings per share. The company’s quarterly revenue was up 14.4% on a year-over-year basis. Analysts expect that Gentiva Health Services will post $0.87 EPS for the current fiscal year.

Gentiva Health Services, Inc (NASDAQ:GTIV) is engaged in providing home health services and hospice services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.